ALAR <6785.TWO> SAYS CO SUBMITS APPLICATION TO US FDA FOR PHASE II CLINICAL TRIAL OF ALA-3000 FOR DEPRESSION TREATMENT

Reuters · 1d ago

Please log in to view news